Studies how melanoma cells use sugar to grow
Tests a labeled glucose infusion to study metabolism in adults with melanoma.
Plain-language title generated from the registry record
Registry title: Metabolic Phenotypes in Melanoma
Key facts
- Where
- Melbourne, AustraliaSee the site
Where in Australia
- Peter Mac Callum Cancer CentreMelbourne, AustraliaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Peter MacCallum Cancer Centre, Australia
- Trial code
- NCT05570227
- Record updated
- 6 July 2023
- Original description
This is a single centre, correlative, longitudinal, biomarker study that aims to describe the metabolic features of human melanoma using mass spectrometry.Read full original descriptionShow less
Identification of Metabolic Phenotypes Associated With Prognosis and Therapeutic Response in Patients With Melanoma
This is a single centre, correlative, longitudinal, biomarker study that aims to describe the metabolic features of human melanoma using mass spectrometry.
Inclusion: Patient has provided written informed consent; Male or female aged 18 years or older at written informed consent; Presence of a known melanoma lesion requiring surgical excision or biopsy; Patient is willing and able to comply with the protocol for the duration of the study including undergoing biopsies and receiving a stable isotope infusion (where applicable).
Exclusion: Diabetes mellitus; Patients who meet any of the following criteria will be excluded from receiving a [U-13C]Glucose infusion:; Pregnancy or breast feeding; Patients unable to comply with study procedures and follow up in the opinion of the investigator.